At 12.0% CAGR, Europe Traumatic Brain Injury Diagnostics Equipment Market Projected to be Worth US$ 2,976.48 Million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Europe traumatic brain injury diagnostics equipment market was valued at US$ 1,204.03 million in 2022 and is expected to reach US$ 2,976.48 million by 2030, registering a CAGR of 12.0% from 2022 to 2030. Emergence of portable non-invasive monitoring devices to diagnose TBI patients and growing use of MRI over CT to limit inpatient mortality and marginally reduce diagnostic cost  are among the critical factors attributed to drive the Europe traumatic brain injury diagnostics equipment market growth.

Although CT is often used in emergency settings for detecting life-threatening head injuries, it can miss subtle findings, such as contusions, small areas of hemorrhage, and diffuse axonal injury. As per the Health Economics Resource Center (HERC) report, the research studies revealed that CT has missed 10–20% of the brain abnormalities that magnetic resonance imaging (MRI) distinctively detects. According to an article published by the Journal of Clinical Imaging Science, the inpatient brain MRI was independently associated with lower mortality. Contrastingly, the use of CT in the evaluation and management of severe TBI is attributable to cancer risk and cancer-related mortality due to radiation exposure. Further, according to the Health Economics Resource Center (HERC) report, the comorbidity-adjusted cost of CT scan was US$ 284 for mild TBI and US$ 455 for severe TBI, standing higher than MRI, which was US$ 230 for mild TBI and US$ 309 for severe TBI cases. In 2018, MRI value per unit cost accounted for US$ 732, with a range of US$ 692 to US$ 750 for TBI based on severity. Therefore, MRI is widely used in TBI diagnosis and management to limit mortality rates and marginally reduce diagnostic costs.

On the contrary, the adverse effects of contrast medium/agent hampers the growth of Europe traumatic brain injury diagnostics equipment market.

Based on techniques, the Europe traumatic brain injury diagnostics equipment market is segmented into non-invasive, invasive, and combination techniques. The invasive segment held 50.9% market share in 2022, amassing US$  613.01 million. It is projected to garner US$ 1,475.57  million by 2030 to register 11.6% CAGR during 2022–2030. Furthermore, the non-invasive segment is subcategorized into electroencephalography (EEG), brain–computer interface (BCI), eye tracking and near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), cerebral metabolic rate of oxygen (CMRO2), intracranial pressure, and others. Additionally, invasive segment is subsegmented into cerebral perfusion pressure (CPP) and pressure reactivity index (PRx), partial brain tissue oxygen pressure (PbtO2), cerebral microdialysis (CMD), intracranial pressure, and others.

In terms of device, the Europe traumatic brain injury diagnostics equipment market is bifurcated into imaging devices and monitoring devices. The imaging devices segment held 81.9% share of Europe traumatic brain injury diagnostics equipment market in 2022, amassing US$ 985.54 million. It is anticipated to garner US$ 2,391.09 million by 2030 to expand at 11.7% CAGR during 2022–2030.

By end user, the Europe traumatic brain injury diagnostics equipment market is divided into hospitals and clinics, diagnostic centers, and others. The hospitals and clinics segment held 54.5% share of Europe traumatic brain injury diagnostics equipment market in 2022, amassing US$  656.20 million. It is projected to garner US$ 1,604.46 million by 2030 to expand at 11.8% CAGR from 2022 to 2030.

Based on country, the Europe traumatic brain injury diagnostics equipment market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.2% share of Europe traumatic brain injury diagnostics equipment market in 2022. It was assessed at US$ 351.22 million in 2022 and is likely to hit US$ 846.81 million by 2030, registering a CAGR of 11.6% during 2022–2030.

Key players operating in the Europe traumatic brain injury diagnostics equipment market are GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, Luciole Medical AG, Soterix Medical Inc, Medtronic Plc, Compumedics Ltd, and NeuraSignal Inc, among others.

• In April 2022, NeuraSignal Inc announced the upgradation of its NovaSignal Platform. A new feature called Morphology has been added to the platform, providing advanced analysis of cerebral waveforms. The new feature enabled faster and easier assessment of patients with suspected neurological conditions such as stroke.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com